Active Care Model Predicts Disease Course for Prostate Cancers

Active Care Model Predicts Disease Course for Prostate Cancers

For many men, prostate cancers are extremely slow-growing — patients often can be monitored periodically through blood tests, biopsies and MRI without necessarily needing treatment. Johns Hopkins experts have a precision medicine tool — called Active Care — that employs sophisticated statistical modeling and all of the patient’s prostate-specific antigen (PSA) protein level tests, biopsy results and other clinical information to estimate the chance that the cancer is slow-growing or more aggressive.

 READ HERE
SEE ALL NEWS
Recent Posts
Podcast: Colorectal Cancer Why age matters when it comes to cancer Liquid Biopsy Predicts Response in Patients with Advanced Lung Cancer Experimental Drug Combination Shows Promise Against Hard-to-Treat Tumors What are the risk factors for Pancreatic Cancer? New Lung Tumor Scoring System Prostate Cancer: Advancements in Screenings 5 Healthy Habits That Help You During Lung Cancer Treatment Six Mammogram Myths